Health Novo Nordisk’s Drug May Enhance Biogen’s Alzheimer’s Strategies Biogen Inc. CEO Chris Viehbacher expressed optimism that a successful trial of Novo Nordisk A/S’s weight-loss drug could pave the way for innovative treatments... Editorial3 days ago